Search by Drug Name or NDC
NDC 71399-0487-06 Sodium Sulfacetamide 8% and Sulfur 4% 80; 40 mg/mL; mg/mL Details
Sodium Sulfacetamide 8% and Sulfur 4% 80; 40 mg/mL; mg/mL
Sodium Sulfacetamide 8% and Sulfur 4% is a TOPICAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Akron Pharma Inc.. The primary component is SULFACETAMIDE SODIUM; SULFUR.
Product Information
| NDC | 71399-0487 |
|---|---|
| Product ID | 71399-0487_9ba64c38-3ad2-4399-8cd2-666065331575 |
| Associated GPIs | 90059903201810 |
| GCN Sequence Number | 066791 |
| GCN Sequence Number Description | sulfacetamide sodium/sulfur SUSPENSION 8 %-4 % TOPICAL |
| HIC3 | Q5S |
| HIC3 Description | TOPICAL SULFONAMIDES |
| GCN | 29180 |
| HICL Sequence Number | 003344 |
| HICL Sequence Number Description | SULFACETAMIDE SODIUM/SULFUR |
| Brand/Generic | Generic |
| Proprietary Name | Sodium Sulfacetamide 8% and Sulfur 4% |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SULFACETAMIDE SODIUM, SULFUR |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | TOPICAL |
| Active Ingredient Strength | 80; 40 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | SULFACETAMIDE SODIUM; SULFUR |
| Labeler Name | Akron Pharma Inc. |
| Pharmaceutical Class | Sulfonamide Antibacterial [EPC], Sulfonamides [CS] |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71399-0487-06 (71399048706)
| NDC Package Code | 71399-0487-6 |
|---|---|
| Billing NDC | 71399048706 |
| Package | 473 mL in 1 BOTTLE, PLASTIC (71399-0487-6) |
| Marketing Start Date | 2020-11-09 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |